TSPO and myeloid sarcoma: There is also a need to understand the interaction of oligodendrocytes in MS and their impact upon myelin integrity using TSPO agents in conjunction with DTI, while the use of spectroscopy helps to establish the effects of and amount of neuronal loss [21,22].